Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01696422
Recruitment Status : Active, not recruiting
First Posted : October 1, 2012
Last Update Posted : January 16, 2019
Banco Nacional de Desenvolvimento Economico e Social
Fundação de Amparo à Pesquisa do Estado de São Paulo
Butantan Foundation
Information provided by (Responsible Party):
Butantan Institute